PMC:7172841 / 18988-19151 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T112","span":{"begin":18,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma86583"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T181","span":{"begin":64,"end":72},"obj":"Disease"},{"id":"T182","span":{"begin":64,"end":68},"obj":"Disease"},{"id":"T183","span":{"begin":159,"end":162},"obj":"Disease"}],"attributes":[{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T178","span":{"begin":114,"end":124},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T83","span":{"begin":18,"end":20},"obj":"Chemical"}],"attributes":[{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A84","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-sentences","denotations":[{"id":"T146","span":{"begin":0,"end":163},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T528","span":{"begin":18,"end":23},"obj":"PR:000001136"},{"id":"T529","span":{"begin":64,"end":74},"obj":"SP_7"},{"id":"T530","span":{"begin":107,"end":113},"obj":"UBERON:0002405;GO:0006955"},{"id":"T531","span":{"begin":114,"end":124},"obj":"GO:0006955"},{"id":"T532","span":{"begin":140,"end":153},"obj":"GO:0065007"},{"id":"T61617","span":{"begin":2,"end":7},"obj":"UBERON:0002405"},{"id":"T25057","span":{"begin":49,"end":53},"obj":"PR:000001393"},{"id":"T1218","span":{"begin":124,"end":129},"obj":"UBERON:0002405"},{"id":"T48907","span":{"begin":130,"end":143},"obj":"GO:0065007"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}

{"project":"LitCovid-PubTator","denotations":[{"id":"693","span":{"begin":18,"end":23},"obj":"Gene"},{"id":"694","span":{"begin":36,"end":44},"obj":"Species"},{"id":"695","span":{"begin":64,"end":74},"obj":"Species"}],"attributes":[{"id":"A693","pred":"tao:has_database_id","subj":"693","obj":"Gene:3552"},{"id":"A694","pred":"tao:has_database_id","subj":"694","obj":"Tax:9606"},{"id":"A695","pred":"tao:has_database_id","subj":"695","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(E) Production of IL-1β by PBMCs of patients with CAP caused by SARS-CoV-2 classified into three states of immune activation: intermediate, dysregulation, and MAS."}